Sustained MRD negative remission in del17p and TP53 mutated B cell prolymphocytic leukemia with ibrutinib and venetoclax

Maria Tariq Siddiqui, Allyson Price, Alessandra Ferrajoli, Gautam Borthakur

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Sustained MRD negative remission in del17p and TP53 mutated B cell prolymphocytic leukemia with ibrutinib and venetoclax'. Together they form a unique fingerprint.

Medicine & Life Sciences